DIF

2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID

DIF is found in 16 entries

DIF as free ligands, exist in 16 entries. Examples include 1DVX, 1NR6, 1PXX

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name 2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
Identifiers {2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid
2-[2-[(2,6-dichlorophenyl)amino]phenyl]ethanoic acid
Synonyms DICLOFENAC
Formula C14 H11 Cl2 N O2
Molecular Weight 296.15 g/mol
Type non-polymer
Isomeric SMILES OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
InChI InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)
InChI Key DCOPUUMXTXDBNB-UHFFFAOYSA-N

Chemical Details

Formal Charge 0
Atom Count 30
Chiral Atom Count 0
Chiral Atoms
Bond Count 31
Aromatic Bond Count 12

Drug Info: DrugBank

DrugBank ID DB00586   (Stereoisomeric match)
Name Diclofenac
Groups approved
Description A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. [PubChem]
Synonyms
  • [2-(2,6-Dichloroanilino)phenyl]acetic acid
  • 2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
  • Diclofenac
  • Diclofenac Acid
  • Diclofenaco
Salts
  • Diclofenac epolamine
  • Diclofenac potassium
  • Diclofenac sodium
Brand Names
  • Act Diclo-miso
  • Apo-diclo
  • Apo-diclo Rapide 50 Mg Tablets
  • Apo-diclo SR
  • Apo-diclofenac
Affected Organism Humans and other mammals
Indication For the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.
Pharmacology Diclofenac is an acetic acid nonsteroidal antiinflammatory drug (NSAID) with analgesic and antipyretic properties. Diclofenac is used to treat pain, dysmenorrhea, ocular inflammation, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and actinic keratosis
Mechanism of action The antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of diclofenac. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.
Route of administration
  • intravenous
  • ophthalmic
  • oral
  • rectal
  • topical
Categories
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
ATC-Code
  • D11AX18
  • M01AB05
  • M02AA15
  • S01BC03
AHFS-Code
  • 28:08.04.08
  • 28:08.04.92
CAS number 15307-86-5
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682